⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0nvyCtJyz #SEMERGEN21 @SEMERGENap @gt_hta https://t.co/nXC69dREFA
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Aug 2021 – Oct 2025Where it's discussed
-
X / Twitter188 posts
-
News26 articles
-
Facebook11 posts
-
Blogs10 articles
-
YouTube2 videos
-
Reddit2 posts
AI synopsis
What people are saying
The discussions surrounding the article often include references to other notable studies, such as the STEP trial and SPRINT, with users stating that 'intensive treatment can lead to better outcomes,' and questioning whether 'more aggressive targets should be sought.' The tone ranges from enthusiastic endorsements of the research's potential benefits to critiques of its applicability for older individuals, characterized by terms like 'game changer' and phrases highlighting concerns about risk, which underscores a complex balance between hope and skepticism in the conclusions drawn from the study.
The discussions show a mix of support and critique of the study's findings, with some pointing out flaws or limitations.
Many participants display strong curiosity regarding the implications and details of the study.
The level of engagement varies, with posts reflecting surface-level commentary and deeper dives into methods and outcomes.
While there is recognition of the study's findings, some express skepticism about its practical implications, leading to a more neutral perception of impact.
Abstract in brief
- The study evaluated the effects of intensive versus standard blood pressure treatment in older Chinese patients with hypertension, focusing on a systolic target of 110-130 mm Hg versus 130-150 mm Hg.
- Out of 9,624 patients screened, 8,511 were enrolled, with 4,243 assigned to the intensive treatment and 4,268 to standard treatment; the mean systolic blood pressure was lower in the intensive group after one year.
- Results showed that primary cardiovascular events were significantly lower in the intensive treatment group (35 events) compared to the standard group (196 events), indicating potential benefits of tighter blood pressure control for older patients.
Top posts
Most liked on X and BlueskyPublicado el STEP: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension @NEJM https://t.co/o5ARqf4xK2 https://t.co/l5dBg0lkXq
Regional Clinical Trials Session - Extremely important STEP trial studying intensive BP control in elderly patients by Dr Jun Cai #ESCardioAsia. Paper in @NEJM: https://t.co/7Je1eU6nrO @w_jyg @J_Hendriks1 @HanCardiomd @keithachanmd @mirvatalasnag @aayshacader @escardio https://t.co/58Nk4yTXfR
60~80歳の高血圧患者に対する厳格な降圧治療(110~130mmHg) vs 標準降圧(130~150mmHg) ・主要評価項目:3.5% vs 4.6% → HR=0.74 [95%CI: 0.60-0.92]) ただし、低血圧(HR=1.31)や失神(HR=3.02)が増えそう N Engl J Med.385(14):1268-79,(2021) PMID:34491661 https://t.co/S0r1chIFHi
En ancianos con HTA el tratamiento intensivo con un objetivo de PAs de 110 a menos de 130 mm Hg resultó en una menor incidencia de eventos cardiovasculares que el tratamiento estándar con un objetivo de 130 a menos de 150 mm Hg. #step https://t.co/W3z3n6l2Ml @SVHTA @SVCardio
In older patients with #hypertension, a #BP target of 110 to less than 130 resulted in fewer #cardiovascular events than a target of 130-150, according to a study in @NEJM. #neurotwitter @AANMember https://t.co/qssRoT63mU https://t.co/IeaX8CnnZb
All mentions
Target Blood Pressure Values for High-Risk Patients Explained
Prof. Johannes Mann discusses target blood pressure values for individuals with elevated cardiovascular risk based on the STEP trial presented at the European Society of Cardiology. The conversation interprets results…
Nate Wood: Cooking Lessons for Better Health
Intensive Blood Pressure Control in Older Patients Explained
This week in cardiology, John Mandrola MD discusses the ESC Wrapup Part II, focusing on the trial comparing intensive versus standard blood pressure treatment in older patients. Results indicate significant…
@Lunatic__Fringe @JasonBardi @ValerieAnne1970 This is a dumb article that ignores any nuance we understand of cardiac pathophysilogy. There is Clear evidence that cardiac remodeling is halted and or reversed with more intensive BP control. https://t.co/UaF12uaylL https://t.co/vcNmTCD8gJ
高齢者の血圧管理に関する研究(STEP trial) ・60~80歳の高血圧症患者を110~130mmHg管理群と130~150mmHg管理群に割付 ・primary outcomeのほとんどで厳格治療群の方が有意に有意に良好な結果(脳卒中 HR 0.67, ACS HR 0.67, 急性心不全 HR 0.27)。なお、死亡率は有意差なし https://t.co/N1NWyPMhy0
@Nefrosaurus @AcidoRinon @Dr_Reyner_Solis Ya hay estudios de control intensivo de TA en adultos mayores (60-80a) , sin embargo por sus características, no son adultos mayores frágiles. 10.1056/NEJMoa2111437
14) #STEP: In elderly (110–130 vs. 130–<150 mmHg) ✔️ CV benefit ⚠️ Slight ↑ in hypotension risk
14) #STEP: In elderly (110–130 vs. 130–<150 mmHg) ✔️ CV benefit ⚠️ Slight ↑ in hypotension risk
El STEP en pacientes de edad avanzada. https://t.co/nUyA2Fr9bX
@renecardio4 @AHAMeetings Pero también está el STEP en ancianos. https://t.co/nUyA2Fr9bX
@jpegan10 Feel free to explore exclusion criteria in the trials included here: https://t.co/mXhJcNFqmZ https://t.co/yYlzq6tAiy
RT @gt_hta: #secsemergen23 @PereBeato En
RT @gt_hta: #secsemergen23 @PereBeato En
RT @gt_hta: #secsemergen23 @PereBeato En
RT @gt_hta: #secsemergen23 @PereBeato En
#secsemergen23 @PereBeato En
@kaulcsmc @pnatarajanmd @mchonig @JAMA_current Interesting to compare BP vs LDL target. Guideline readily endorse LDL < 55 in high risk despite no PCSK9i data > 3 yrs . For BP target, Despite SPRINT & STEP trial, we're still debating it https://t.co/aMp9K3DXvr More BP target trials to be done...
@DrAdamBat @nntaleb There is also this https://t.co/Nf78u21bHe and... this https://t.co/571LBxxdJQ
RT @edgarvlermamd: STEP: In older patients w/ hypertension, intensive treatment w/ target
中国での60-80歳の高齢高血圧患者を対象にしたRCT、sBP130未満を目指す治療群の方が通常治療群と比べて心血管イベントが少なく、有害事象は優位差がなかった。 ...これはいうほどpractice-changingなのか
総死亡が減っていないのがやや…。SPRINTでは総死亡リスク低下も認められていて、結果の違いはデザインや選択基準や…といっているがはたして…。 Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/Bbtki6GgAv
@kamleshkhunti @jamessheppard48 @sapcacuk @UCLan @RichardJMcManus @rcgp @docwas @singhak_endo @nsiriwardena @AliRacaniere @ISHBP @JHypertension @scelee1 Age cut offs like 85 are high and yes struggle to see benefit but what’s interesting is benefit seen below that age (yep need to correlate with frailty) and how low do you go…studies like STEP (albeit Chinese population) show it can be achieved…https://t.co/6TGXsvhYMr
@QRStradivarius יש דברים שהניהול שלהם כמעט רק בקהילה, סכרת ילד וכו… לא תמיד יש חידודים אבל sglt כמו שתום כתב זה נחמד ויש nejm על השאלה האלמותית של איזון הדוק או לא ליל״ד משנה שעבדה https://t.co/IAVJZ2mmS2
In older patients with hypertension, intensive treatment with a sBP target of 110 to less than 130 mm Hg resulted in a lower incidence of CV events than standard treatment with a target of 130 to less than 150 mm Hg. https://t.co/ACtDOEKWS1
RT @plum_blaclaw: SPRINTやSTEP研究(中国)から, intensive treatmentについては最早疑う余地はなくなっている。 74歳以下では130/80mmHg未満が治療目標。 75歳以上でも140mmHg未満を目指すこと。 The STEP…
RT @plum_blaclaw: SPRINTやSTEP研究(中国)から, intensive treatmentについては最早疑う余地はなくなっている。 74歳以下では130/80mmHg未満が治療目標。 75歳以上でも140mmHg未満を目指すこと。 The STEP…
SPRINTやSTEP研究(中国)から, intensive treatmentについては最早疑う余地はなくなっている。 74歳以下では130/80mmHg未満が治療目標。 75歳以上でも140mmHg未満を目指すこと。 The STEP trial(2021) https://t.co/E0DpfY4EJ1 #22JCS
RT @uni_pharmacist: 高齢者に対する厳格降圧の有効性 Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/xgAfs0LqHB
高齢者に対する厳格降圧の有効性 Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/xgAfs0LqHB
<論文・症例報告>苅尾 七臣 先生 『Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension』-高齢高血圧患者に対する厳格血圧コントロールの有効性を検討:STEP試験- https://t.co/eZNKlX3dbR
Interesting BP-temperature trends tucked away in the STEP trial appendix & not really remarked upon https://t.co/JOuYfQJlmI https://t.co/EkS3y79VEC
Galera, alguém me consegue esse na moralzinha? A Alexandra não conseguiu :/ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension September 30, 2021 N Engl J Med 2021; 385:1268-1279 DOI: 10.1056/NEJMoa2111437
- Effect of Salt Substitution on Cardiovascular Events and Death - Maintenance or Discontinuation of Antidepressants in Primary Care - Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
RT @Fizz_DI: 60~80歳の高血圧患者に対する厳格な降圧治療(110~130mmHg) vs 標準降圧(130~150mmHg) ・主要評価項目:3.5% vs 4.6% → HR=0.74 [95%CI: 0.60-0.92]) ただし、低血圧(HR=1.31)…
60~80歳の高血圧患者に対する厳格な降圧治療(110~130mmHg) vs 標準降圧(130~150mmHg) ・主要評価項目:3.5% vs 4.6% → HR=0.74 [95%CI: 0.60-0.92]) ただし、低血圧(HR=1.31)や失神(HR=3.02)が増えそう N Engl J Med.385(14):1268-79,(2021) PMID:34491661 https://t.co/S0r1chIFHi
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. Reply https://t.co/VNqYwd3iKw https://t.co/clhvNs8aXR
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/kJsERdHblE https://t.co/sUfw2K1lvX
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/a7qvlWa95F https://t.co/KhJJtQqxqZ
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/gNhtQipgd4 https://t.co/CfcMm39jNG
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/r8Xz8Vzw8l https://t.co/U4iFrpro9P
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/1DztyLUSAi
RT @chinghuisia: Regional Clinical Trials Session - Extremely important STEP trial studying intensive BP control in elderly patients by Dr…
#074 Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension N Engl J Med 2021;385:1268-79. STEP試験 60〜80歳の中国人でSBPを110〜130にコントロールすると130〜150の時より複合エンドポイント発生のリスクを下げる(HR0.74)
@PracUpCardio @CardioIAN #CardioTwitter https://t.co/Jj2fc4KhKV
RT @chinghuisia: Regional Clinical Trials Session - Extremely important STEP trial studying intensive BP control in elderly patients by Dr…
RT @chinghuisia: Regional Clinical Trials Session - Extremely important STEP trial studying intensive BP control in elderly patients by Dr…
RT @chinghuisia: Regional Clinical Trials Session - Extremely important STEP trial studying intensive BP control in elderly patients by Dr…
RT @chinghuisia: Regional Clinical Trials Session - Extremely important STEP trial studying intensive BP control in elderly patients by Dr…
RT @chinghuisia: Regional Clinical Trials Session - Extremely important STEP trial studying intensive BP control in elderly patients by Dr…
RT @chinghuisia: Regional Clinical Trials Session - Extremely important STEP trial studying intensive BP control in elderly patients by Dr…
RT @chinghuisia: Regional Clinical Trials Session - Extremely important STEP trial studying intensive BP control in elderly patients by Dr…
Regional Clinical Trials Session - Extremely important STEP trial studying intensive BP control in elderly patients by Dr Jun Cai #ESCardioAsia. Paper in @NEJM: https://t.co/7Je1eU6nrO @w_jyg @J_Hendriks1 @HanCardiomd @keithachanmd @mirvatalasnag @aayshacader @escardio https://t.co/58Nk4yTXfR
RT @mi_cardiologo: En ancianos con HTA el tratamiento intensivo con un objetivo de PAs de 110 a menos de 130 mm Hg resultó en una menor inc…
RT @mi_cardiologo: En ancianos con HTA el tratamiento intensivo con un objetivo de PAs de 110 a menos de 130 mm Hg resultó en una menor inc…
RT @mi_cardiologo: En ancianos con HTA el tratamiento intensivo con un objetivo de PAs de 110 a menos de 130 mm Hg resultó en una menor inc…
RT @mi_cardiologo: En ancianos con HTA el tratamiento intensivo con un objetivo de PAs de 110 a menos de 130 mm Hg resultó en una menor inc…
RT @mi_cardiologo: En ancianos con HTA el tratamiento intensivo con un objetivo de PAs de 110 a menos de 130 mm Hg resultó en una menor inc…
RT @mi_cardiologo: En ancianos con HTA el tratamiento intensivo con un objetivo de PAs de 110 a menos de 130 mm Hg resultó en una menor inc…
A friendly reminder from our Academic Chief, Dr. Alex Pennekamp(@AvogadrosHomie) that the NEJM Journal Club will be closing soon. https://t.co/PTyMh2rn1v
RT @mi_cardiologo: En ancianos con HTA el tratamiento intensivo con un objetivo de PAs de 110 a menos de 130 mm Hg resultó en una menor inc…
RT @mi_cardiologo: En ancianos con HTA el tratamiento intensivo con un objetivo de PAs de 110 a menos de 130 mm Hg resultó en una menor inc…
En ancianos con HTA el tratamiento intensivo con un objetivo de PAs de 110 a menos de 130 mm Hg resultó en una menor incidencia de eventos cardiovasculares que el tratamiento estándar con un objetivo de 130 a menos de 150 mm Hg. #step https://t.co/W3z3n6l2Ml @SVHTA @SVCardio
ALVO DE PA NOS IDOSOS O STEP foi um estudo multicêntrico e prospectivo, com 8511 pacientes chineses de 60 a 80 anos e com hipertensão. Eles foram randomizados para o tratamento intensivo (meta de PAS de 110-130mmHg) ou tratamento padrão (130-150 mmHg) https://t.co/atV4PIFAmB
<join us!> Tomorrow: The Christ Hospital Internal Medicine Residency leads NEJM's Online Journal Club Discussion of, "Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension." https://t.co/MSN6ou9Yzu @TCHIMRes @NEJMres360 https://t.co/DOZYxMs0Kl
RT @nishiki8885: 続いて夜久先生 ✔︎ 高齢者の高血圧管理の目安は日本・米国・欧州で一貫していない
RT @nishiki8885: 続いて夜久先生 ✔︎ 高齢者の高血圧管理の目安は日本・米国・欧州で一貫していない
RT @nishiki8885: 続いて夜久先生 ✔︎ 高齢者の高血圧管理の目安は日本・米国・欧州で一貫していない
続いて夜久先生 ✔︎ 高齢者の高血圧管理の目安は日本・米国・欧州で一貫していない
【S21-4】中国の高齢者(60-80歳)を対象にした研究の参加者は60-69歳が多く、高齢者でも厳格な降圧が望ましいとは一概に言えない。 https://t.co/tdwkPigcUD #jsphcs2021
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/pakN3tzbJb
The Christ Hospital Internal Medicine Residency @TCHIMRes is pleased to host NEJM's Online Journal Club Nov. 15 - 24th! https://t.co/MSN6ou9Yzu Join us in discussing the paper, "Trial of Intensive Blood Pressure Control in Older Adults with Hypertension."
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/ctWjS9HZSR
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/z0RfWsX1ZO
Tighter BP control showed a statistically significant decrease in stroke and ACS. All-cause mortality did not decrease in the tighter BP control group. #MedTwitter Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/pLw64cX6t8
RT @ArieBlitzMD: In a Chinese RCT, older patients with hypertension, intensive treatment with a systolic blood-pressure target of 110-130 m…
RT @MontefioreGeri: Join us for journal club Thurs 10/21 at 2PM! Please be prepared to discuss the article below. Looking forward to conti…
RT @m_aldemerdash: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. 2021 from @NEJM #Nephpearls https://t.co…
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. 2021 from @NEJM #Nephpearls https://t.co/vS0JV00Ozz
Join us for journal club Thurs 10/21 at 2PM! Please be prepared to discuss the article below. Looking forward to continue our discussions on evidence based blood pressure goals in the older adult population! https://t.co/9yDLH0hd6y
RT @w_kawachan: ★43回日本高血圧学会:特別企画見どころ★ 【会長超特急企画】10月17日 (日) 15:00〜30分 欧州心臓病学会とNEJMで発表された、Trial of Intensive Blood-Pressure Control in Older P…
RT @w_kawachan: ★43回日本高血圧学会:特別企画見どころ★ 【会長超特急企画】10月17日 (日) 15:00〜30分 欧州心臓病学会とNEJMで発表された、Trial of Intensive Blood-Pressure Control in Older P…
RT @w_kawachan: ★43回日本高血圧学会:特別企画見どころ★ 【会長超特急企画】10月17日 (日) 15:00〜30分 欧州心臓病学会とNEJMで発表された、Trial of Intensive Blood-Pressure Control in Older P…
RT @w_kawachan: ★43回日本高血圧学会:特別企画見どころ★ 【会長超特急企画】10月17日 (日) 15:00〜30分 欧州心臓病学会とNEJMで発表された、Trial of Intensive Blood-Pressure Control in Older P…
★43回日本高血圧学会:特別企画見どころ★ 【会長超特急企画】10月17日 (日) 15:00〜30分 欧州心臓病学会とNEJMで発表された、Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.の著者Weili Zhang先生がアジア人の厳格降圧の有用性を認めたSTEP研究を口演。
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/cBU5F8buiW
2/2 resulted in a lower incidence of cardiovascular events than standard treatment with a target of 130 to less than 150 mm Hg. https://t.co/boYIO9cQX5 https://t.co/iullmG64WI
1/2 Optimal blood pressure helps our brains age more slowly https://t.co/HAIUOAquzO via @medical_xpress In older patients with hypertension, intensive treatment with a systolic blood-pressure target of 110 to less than 130 mm Hg .. https://t.co/boYIO9cQX5 https://t.co/iullmG64WI
これがウワサのSTEP studyか。 高齢者の血圧管理でもSBP 110-130mmHg目指した方がいい? Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/7hb2Df21z0
RT @RevistaMFSamfyc: Ensayo de control intensivo de la presión arterial en pacientes mayores con hipertensión https://t.co/5ycUI3ELeU PMID…
Ensayo de control intensivo de la presión arterial en pacientes mayores con hipertensión https://t.co/5ycUI3ELeU PMID 34491661
RT @RouchLaure: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension @NEJM https://t.co/KZU5HpdUwE
https://t.co/tbFl7hOJT2
【NEJM】 高齢者の血圧を130mmHg未満にするとリスクがある…というのが通説な中、チャレンジングな研究が発表されましたね
RT @aquariusmed: #ジャーナル 高血圧を有する 60~80 歳の中国人患者 8,511 例を対象としたRCT。強化治療(目標収縮期血圧 110 mmHg 以上 130 mmHg 未満)と標準治療(目標収縮期血圧 130 mmHg 以上 150 mmHg 未満)を…
#ジャーナル 高血圧を有する 60~80 歳の中国人患者 8,511 例を対象としたRCT。強化治療(目標収縮期血圧 110 mmHg 以上 130 mmHg 未満)と標準治療(目標収縮期血圧 130 mmHg 以上 150 mmHg 未満)を比較。強化治療で心血管イベントの発生率が低下。有害事象も低血圧程度 https://t.co/XOca5Oy2uW https://t.co/xtWDhOjrqn
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/1rNBWDQ5wV
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/FQ5zOVEKHT
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension @NEJM https://t.co/KZU5HpdUwE
RT @martinezvelilla: In older patients with hypertension, intensive treatment with a systolic blood pressure the target of 110 to less than…
RT @aquariusmed: #ジャーナル 高血圧を有する 60~80 歳の中国人患者 8,511 例を対象としたRCT。強化治療(目標収縮期血圧 110 mmHg 以上 130 mmHg 未満)と標準治療(目標収縮期血圧 130 mmHg 以上 150 mmHg 未満)を…
RT @aquariusmed: #ジャーナル 高血圧を有する 60~80 歳の中国人患者 8,511 例を対象としたRCT。強化治療(目標収縮期血圧 110 mmHg 以上 130 mmHg 未満)と標準治療(目標収縮期血圧 130 mmHg 以上 150 mmHg 未満)を…
#ジャーナル 高血圧を有する 60~80 歳の中国人患者 8,511 例を対象としたRCT。強化治療(目標収縮期血圧 110 mmHg 以上 130 mmHg 未満)と標準治療(目標収縮期血圧 130 mmHg 以上 150 mmHg 未満)を比較。強化治療群の心血管イベントの発生率が低下。 https://t.co/XOca5OPDTw https://t.co/7z0FM95mdx
In a Chinese RCT, older patients with hypertension, intensive treatment with a systolic blood-pressure target of 110-130 mm Hg resulted in a lower incidence of cardiovascular events than standard treatment with a target of 130-150 mm Hg. | @nejm https://t.co/hCWwZfYp2S
RT @jacabreracardio:
RT @jacabreracardio:
SFHTA article de la semaine: STEP Study: intensive vs. standard blood pressure control among older hypertensive patients Etude chinoise, randomisée contrôlée confirme l’intérêt d’une stratégie de prise en charge intensive de l'HTA chez les patients âgés. https://t.co/FkukeBmzwN https://t.co/5M1BBWxTDP
RT @jacabreracardio:
RT @jacabreracardio:
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/uIl0KwxgJ5
RT @YoungGeris: The debate about BP control in older adults continues... cc @ToddOly @MeBeckett https://t.co/7EgqvBe1ao
RT @NeurologyToday: In older patients with #hypertension, a #BP target of 110 to less than 130 resulted in fewer #cardiovascular events tha…
In older patients with #hypertension, a #BP target of 110 to less than 130 resulted in fewer #cardiovascular events than a target of 130-150, according to a study in @NEJM. #neurotwitter @AANMember https://t.co/qssRoT63mU https://t.co/IeaX8CnnZb
The debate about BP control in older adults continues... cc @ToddOly @MeBeckett https://t.co/7EgqvBe1ao
RT @doctorheart00: El tratamiento de la Hipertensión en adulto mayor de 60 debe de ser intensivo para reducir la muerte cardiovascular. @SI…
RT @kamleshkhunti: In older patients (60-80 yrs) with hypertension, intensive treatment with SBP target of 110 - 130 mmHg showed ⬇️cardiov…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @martinezvelilla: In older patients with hypertension, intensive treatment with a systolic blood pressure the target of 110 to less than…
RT @kamleshkhunti: In older patients (60-80 yrs) with hypertension, intensive treatment with SBP target of 110 - 130 mmHg showed ⬇️cardiov…
RT @doctorheart00: El tratamiento de la Hipertensión en adulto mayor de 60 debe de ser intensivo para reducir la muerte cardiovascular. @SI…
RT @doctorheart00: El tratamiento de la Hipertensión en adulto mayor de 60 debe de ser intensivo para reducir la muerte cardiovascular. @SI…
El tratamiento de la Hipertensión en adulto mayor de 60 debe de ser intensivo para reducir la muerte cardiovascular. @SIAC_cardio NEJM https://t.co/FUuivE3UXm
RT @kaulcsmc: https://t.co/WVaudH3dKw 1/ A few questions on STEP 1.Should trial have been truncated prematurely, given no mortality benefit…
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/4EKx7Lc9LX
RT @almucastro01: Publicado el STEP: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension @NEJM https://t.co/o…
RT @drjohnmorley: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/oek8EHtB1p
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @almucastro01: Publicado el STEP: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension @NEJM https://t.co/o…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/nBz1qBlPVY
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @almucastro01: Publicado el STEP: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension @NEJM https://t.co/o…
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/bABZilMkz1
New data of blood pressure target in older adults with hypertension, but I think this goal difficult to achieve in real practice without risk of complications such as fall. https://t.co/NdwEEic264
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/oek8EHtB1p
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @almucastro01: Publicado el STEP: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension @NEJM https://t.co/o…
RT @almucastro01: Publicado el STEP: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension @NEJM https://t.co/o…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/VOKEkZRzUz via @NEJM #EASD2021
Publicado el STEP: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension @NEJM https://t.co/o5ARqf4xK2 https://t.co/l5dBg0lkXq
RT @vic_pallares: ⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0n…
⚠️More evidence⤵️ Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | @NEJM https://t.co/b0nvyCtJyz #SEMERGEN21 @SEMERGENap @gt_hta https://t.co/nXC69dREFA
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. #Hypertension @NEJM https://t.co/wgU0LMDQ6G
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/DcTuuV2Nwb
RT @VijayKunadian: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM #ESCCongress https://t.co/anJfr3JA…
#論文紹介 血圧の目標値に関する報告 高血圧患者の治療目標値を130-150mmHgに設定しているところを、110-130mmHgに変更するというNEJMの論文。 ✅脳卒中が-33% ✅急性coronary syndrome-33% ✅急性decompensated heart failure-73% ✅心疾患による死亡-28% キレがいい https://t.co/8WG4RwKnPD
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/uDckgHUFQI #medtwitter
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension The trial results suggest that more aggressive lower targets improve outcomes even in the elderly, for whom there had been inconsistent evidence from epidemiological studies. https://t.co/wkX4hLvT8B
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/jQqopkym9i https://t.co/N959fzl8Ys
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/fXns9LpMGp
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM - target 110-130 for SBP was best https://t.co/LdPpRzuzaL
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/0gK3Ii3Zr4
RT @TGijonConde: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/SNrPieTJpe @SEHLELHA140…
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/EUBNx7vzEl
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/EbT8skSh2Q
Olderといっても60-80歳、うちだとまだ若い世代。。。 Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/rgqNdWIq48
RT @xinggang_wang: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/wxTiDyDpr9
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM - STEP not SHEP! https://t.co/0LriSW7AcI
RT @TGijonConde: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/SNrPieTJpe @SEHLELHA140…
RT @xinggang_wang: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/wxTiDyDpr9
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/wxTiDyDpr9
RT @TGijonConde: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/SNrPieTJpe @SEHLELHA140…
RT @TGijonConde: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/SNrPieTJpe @SEHLELHA140…
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/SNrPieTJpe @SEHLELHA140_90
RT @pacovr53: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/lR1RKwMRUC
RT @pacovr53: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/lR1RKwMRUC
RT @rafabravo: Hala a dejarlos a tos mareaos , agarrandose a las esquinas. Trial of Intensive Blood-Pressure Control in Older Patients with…
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension https://t.co/hkqGZnNk2Y
RT @FormigaFrancesc: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/kIMJjr63Xx
RT @FormigaFrancesc: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/kIMJjr63Xx
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/7NXtcu3dV3
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/lR1RKwMRUC
RT @rafabravo: Hala a dejarlos a tos mareaos , agarrandose a las esquinas. Trial of Intensive Blood-Pressure Control in Older Patients with…
RT @FormigaFrancesc: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/kIMJjr63Xx
RT @FormigaFrancesc: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/kIMJjr63Xx
Hala a dejarlos a tos mareaos , agarrandose a las esquinas. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/qm4P1jy8Bw
RT @FormigaFrancesc: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/kIMJjr63Xx
RT @AmarPut: Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM https://t.co/XIGZHrLOPH @escardio #ESCCon…